Ann Hepatobiliary Pancreat Surg.  2020 Nov;24(4):454-459. 10.14701/ahbps.2020.24.4.454.

Simultaneous liver-kidney transplantation: A single-center experience in Korea

• Kim M
• Hwang S
• Ahn CS
• Moon DB
• Ha TY
• Song GW
• Jung DH
• Shin S
• Kim YH
• Ha HS
• Hong JJ
• Kim IO
• Han DJ
• Lee SG

• KMID: 2508854
• DOI: http://doi.org/10.14701/ahbps.2020.24.4.454

Abstract

Backgrounds/Aims
Simultaneous liver and kidney transplantation (SLKT) has been established as the treatment of choice for patients with concurrent end‐stage liver and end‐stage kidney diseases. The objective of this study was to analyze the nationwide incidence of SLKT in Korea and the outcomes of SLKT in a high-volume transplant center.
Methods
Databases of the Korean Network for Organ Sharing (KONOS) and Asan Medical Center from 2000 to 2019 were retrospectively reviewed to determine the incidence of SLKT.
Results
During 20 years from 2000 to 2019, deceased donor SLKT was performed for 38 cases in the KONOS database. The proportion of deceased donor SLKT was 0.6% (20 of 3333) before adoption of MELD score, which was significantly increased to 1.2% (18 of 1524) after the adoption of MELD score (p=0.034). In our institution, there were 11 cases of SLKT (2 cases with deceased donors and 9 cases with living donors). SLKT accounted for 0.2% (11 of 6468) of total liver transplantation volume. During follow-up, five patients died due to hepatocellular carcinoma recurrence (n=2), infection (n=2), or unknown cause (n=1). The 1-year and 10-year overall patient survival rates were 90.9% and 81.8%, respectively.
Conclusions
Results of this study revealed that the incidence of deceased donor SLKT was very low. An increase of such incidence is not anticipated unless the number of deceased donors is markedly increased. Currently, sequential living donor liver transplantation and kidney transplantation with deceased or living donors are mainstays of transplantation rather than SLKT in our institution.

Keyword

Hepatocellular carcinoma; Donor shortage; Chronic renal failure; Acute kidney injury; Living donor

Figure

• 

  Fig. 1 Kaplan-Meier analysis of overall patient survival in 11 patients who underwent simultaneous liver-kidney transplantation.

Reference

1. Margreiter R, Kramar R, Huber C, Steiner E, Niederwieser D, Judmaier G, et al. 1984; Combined liver and kidney transplantation. Lancet. 1:1077–1078. DOI: 10.1016/S0140-6736(84)91486-7. PMID: 6144007.

2. Formica RN, Aeder M, Boyle G, Kucheryavaya A, Stewart D, Hirose R, et al. 2016; Simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of scarce resources. Am J Transplant. 16:758–766. DOI: 10.1111/ajt.13631. PMID: 26603142.

3. Lum EL, Cárdenas A, Martin P, Bunnapradist S. 2019; Current status of simultaneous liver-kidney transplantation in the United States. Liver Transpl. 25:797–806. DOI: 10.1002/lt.25444. PMID: 30861294.

4. Miles CD, Westphal S, Liapakis A, Formica R. 2018; Simultaneous liver-kidney transplantation: impact on liver transplant patients and the kidney transplant waiting list. Curr Transplant Rep. 5:1–6. DOI: 10.1007/s40472-018-0175-z. PMID: 29564203. PMCID: PMC5843696.

5. Wi W, Hahm TS, Kim GS. 2017; A case series on simultaneous liver and kidney transplantation: do we need intraoperative renal replacement therapy? Korean J Anesthesiol. 70:467–476. DOI: 10.4097/kjae.2017.70.4.467. PMID: 28794844. PMCID: PMC5548951.

6. Nah YW, Nam CW, Suh JH, Cha HJ, Kim GY, Park SJ, et al. 2008; Isolated acute cellular rejection of the liver after simultaneous liver and kidney transplantation: a case report. Transplant Proc. 40:2832–2834. DOI: 10.1016/j.transproceed.2008.08.021. PMID: 18929875.

7. Chae MS, Kim Y, Oh SA, Jeon Y, Choi HJ, Kim YH, et al. 2018; Intraoperative management of a patient with impaired cardiac function undergoing simultaneous ABO-compatible liver and ABO-incompatible kidney transplant from 2 living donors: a case report. Transplant Proc. 50:3988–3994. DOI: 10.1016/j.transproceed.2018.08.017. PMID: 30471833.

8. Kim K, Jeong DW, Lee YH, Kim YG, Moon JY, Jeong KH, et al. 2017; Everolimus-induced systemic serositis after simultaneous liver and kidney transplantation: a case report. Transplant Proc. 49:181–184. DOI: 10.1016/j.transproceed.2016.11.026. PMID: 28104132.

9. Go J, Ko K, Jun D, Kwon SK, Han S, Kim YH, et al. 2019; A half-century 3000 cases of kidney transplant experiences in a single hospital: the longest registry in Korea. Transplant Proc. 51:2559–2567. DOI: 10.1016/j.transproceed.2019.04.083. PMID: 31439328.

10. Gleisner AL, Jung H, Lentine KL, Tuttle-Newhall J. 2012; Renal dysfunction in liver transplant candidates: evaluation, classification and management in contemporary practice. J Nephrol Ther. Suppl 4(SI Kidney Transplantation):006. DOI: 10.4172/2161-0959.S4-006. PMID: 32874772. PMCID: PMC7457375.

11. O'Riordan A, Wong V, McCormick PA, Hegarty JE, Watson AJ. 2006; Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant. 21:2630. DOI: 10.1093/ndt/gfl247. PMID: 16735393.

12. Lee J, Lee JG, Jung I, Joo DJ, Kim SI, Kim MS. Advisory Committee on Improving Liver Allocation. 2019; Development of a Korean liver allocation system using model for end stage liver disease scores: a nationwide, multicenter study. Sci Rep. 9:7495. DOI: 10.1038/s41598-019-43965-2. PMID: 31097768. PMCID: PMC6522508.

13. Min SI, Ahn C, Han DJ, Kim SI, Chung SY, Lee SK, et al. 2015; To achieve national self-sufficiency: recent progresses in deceased donation in Korea. Transplantation. 99:765–770. DOI: 10.1097/TP.0000000000000412. PMID: 25226175.

14. Ha HS, Hong JJ, Kim IO, Lee SR, Lee AY, Ha TY, et al. 2019; Deceased donor liver transplantation under the Korean model for end-stage liver disease score-based liver allocation system: 2-year allocation results at a high-volume transplantation center. Korean J Transplant. 33:112–117. DOI: 10.4285/jkstn.2019.33.4.112.

15. Gautier S, Monakhov A, Tsiroulnikova O, Voskanov M, Miloserdov I, Dzhanbekov T, et al. 2020; Deceased vs living donor grafts for pediatric simultaneous liver-kidney transplantation: a single-center experience. J Clin Lab Anal. 34:e23219. DOI: 10.1002/jcla.23219. PMID: 31967359. PMCID: PMC7307349.

16. Fong TL, Khemichian S, Shah T, Hutchinson IV, Cho YW. 2012; Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure. Transplantation. 94:411–416. DOI: 10.1097/TP.0b013e3182590d6b. PMID: 22805440.

17. Kitajima K, Ogawa Y, Miki K, Kai K, Sannomiya A, Iwadoh K, et al. 2017; Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor. Liver Transpl. 23:315–323. DOI: 10.1002/lt.24676. PMID: 27862900.

18. Marujo WC, Barros MF, Cury RA, Pacheco-Silva A, Sette H Jr. 1999; Successful combined kidney-liver right lobe transplant from a living donor. Lancet. 353:641. DOI: 10.1016/S0140-6736(98)05658-X. PMID: 10030332.

19. Lee SG, Moon DB, Hwang S, Ahn CS, Kim KH, Song GW, et al. 2015; Liver transplantation in Korea: past, present, and future. Transplant Proc. 47:705–708. DOI: 10.1016/j.transproceed.2015.02.015. PMID: 25891715.

20. Yoon YI, Song GW, Lee SG, Hwang S, Kim KH, Kim SH, et al. 2018; Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma. J Hepatol. 68:1153–1162. DOI: 10.1016/j.jhep.2018.02.002. PMID: 29452208.